Jul 25, 2024, 15:01
Michael Duruisseaux: Toxicities associated with sequential or combined use of small targeted therapies in lung cancer
Michael Duruisseaux, Thoracic Oncologist at HCL – Hospices Civils de Lyon, shared on X:
“Hot of the press: very pleased to share this team work “Toxicities associated with sequential or combined use of immune checkpoint inhibitors and small targeted therapies in lung cancer”.
Led by Thomas Pierret and Dr Desage.”
Source: Michael Duruisseaux/X
Authors: Anne-Laure Désage, Michael Duruisseaux, Claire Lafitte, Sophie Bayle-Bleuez, Christos Chouaid. Pierre Fournel, Thomas Pierret
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 08:59
Nov 13, 2024, 08:39